Mar 22, 2021 / 06:30PM GMT
Ryan M. Todd - Piper Sandler & Co., Research Division - Research Analyst
Great. Thanks. Welcome, everybody, to a fireside discussion here. We're lucky enough to have a large chunk of the management team here from Phillips 66. We've got Greg Garland, Chairman and CEO. We've got Kevin, the CFO; Mark, who is -- has been heading up the Chemicals business and President and COO; and Jeff Dietert here with us for Investor Relations. So thanks, everybody, for joining. It's really a pleasure to have you here at the conference. We really appreciate your participation today.
Questions and Answers:
Ryan M. Todd - Piper Sandler & Co., Research Division - Research AnalystIf we could start it off maybe with a couple on the strategy side. Historically, you've been composed of 4 businesses each with, let's call it, mid-cycle EBITDA potential, somewhere in the $1.5 billion to $2.5-plus billion range. I think you've talked about a combined mid-cycle business that was maybe roughly around $9 billion a year in EBITDA or $6 billion to $7 billion a year in cash flow. I